SEC Company Response from Vistagen Therapeutics, Inc. (VTGN) (CIK 0001411685) (VTGN) — May 8, 2020
Vistagen Therapeutics, Inc. (VTGN) (CIK 0001411685)
Date: May 8, 2020 · CIK: 0001411685 · Accession: 0001654954-20-005108
AI Filing Summary & Sentiment
File numbers found in text: 333-237968
Letter
VIA EDGAR United States Securities and Exchange Commission Attention: Ms. Irene Paik VistaGen Therapeutics, Inc. Registration Statement on Form S-3 (File No. 333-237968)
RE:
Dear Mr. Gabor,
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, VistaGen Therapeutics, Inc., a Nevada corporation (the “Registrant”), hereby requests acceleration of the effective date of the Registration Statement referred to above so that it may become effective at 10:00 a.m. Eastern Standard Time on May 13, 2020, or as soon as practicable thereafter.
Upon grant of our request to accelerate effectiveness, we would appreciate your communicating with our counsel, Disclosure Law Group, a Professional Corporation, by calling Ms. Jessica R. Sudweeks at (619) 272-7063, to confirm the exact time at which the Registration Statement was declared effective.
Very
truly yours,
VISTAGEN
THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm vtgncorresp_may2020 May 11, 2020 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Ms. Irene Paik RE: VistaGen Therapeutics, Inc. Registration Statement on Form S-3 (File No. 333-237968) Dear Mr. Gabor, Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, VistaGen Therapeutics, Inc., a Nevada corporation (the “Registrant”), hereby requests acceleration of the effective date of the Registration Statement referred to above so that it may become effective at 10:00 a.m. Eastern Standard Time on May 13, 2020, or as soon as practicable thereafter. Upon grant of our request to accelerate effectiveness, we would appreciate your communicating with our counsel, Disclosure Law Group, a Professional Corporation, by calling Ms. Jessica R. Sudweeks at (619) 272-7063, to confirm the exact time at which the Registration Statement was declared effective. Very truly yours, VISTAGEN THERAPEUTICS, INC. /s/ Shawn K. Singh Shawn K. Singh President and Chief Executive Officer cc: Jessica Sudweeks Partner Disclosure Law Group, a Professional Corporation